Chronic Hepatitis C — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for chronic hepatitis c. 40 active patents protecting 3 drugs from 2+ originators. First major cliff: 2030. Daily refresh.

3
Approved drugs
40
Active US patents
64/100
Avg vulnerability
—
Annual revenue covered

Originators in Chronic Hepatitis C

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

AbbVie 36 patents Merck & Co. 4 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating chronic hepatitis c. Each bar = one year. Y-axis scaled to peak year (10 patents).

2
27
1
29
10
30
3
31
8
32
6
34
8
35
2
36

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Mavyret
GLECAPREVIR
 AbbVie 36 40 — 2030-06-10
Victrelis
BOCEPREVIR
 Merck & Co. 2 83 — 2027-03-17
Zepatier
ELBASVIR
 Merck & Co. 2 68 — 2029-07-24

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8119602 Victrelis method of use 85 2027-03-17
7772178 Victrelis method of use 80 2027-11-11
7973040 Zepatier method of use 68 2029-07-24
8871759 Zepatier method of use 68 2031-05-04
11484534 Mavyret method of use 53 2034-03-14
10028937 Mavyret method of use 51 2030-06-10
10028937 Mavyret method of use 51 2030-06-10
10039754 Mavyret method of use 51 2030-06-10
10039754 Mavyret method of use 51 2030-06-10
9586978 Mavyret method of use 51 2030-11-06

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9321807 Mavyret composition of matter 0 2035-06-05
9321807 Mavyret composition of matter 0 2035-06-05
RE48923 Mavyret composition of matter 0 2035-05-08
RE48923 Mavyret composition of matter 0 2035-05-08
8937150 Mavyret composition of matter 0 2032-05-18
8937150 Mavyret composition of matter 0 2032-05-18
11246866 Mavyret formulation 33 2036-06-24
11246866 Mavyret other 45 2036-12-24
9321807 Mavyret other 45 2035-12-05
9321807 Mavyret other 45 2035-12-05

Related